Cellectis S.A. (LON:0WA2)
2.455
+0.145 (6.28%)
At close: Aug 1, 2025
Cellectis Employees
As of December 31, 2024, Cellectis had 222 total employees, including 216 full-time and 6 part-time employees. The number of employees increased by 1 or 0.45% compared to the previous year.
Employees
222
Change (1Y)
1
Growth (1Y)
0.45%
Revenue / Employee
193.49K GBP
Profits / Employee
-213.93K GBP
Market Cap
156.90M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 222 | 1 | 0.45% |
Dec 31, 2023 | 221 | -16 | -6.75% |
Dec 31, 2022 | 237 | -63 | -21.00% |
Dec 31, 2021 | 300 | 19 | 6.76% |
Dec 31, 2020 | 281 | 17 | 6.44% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
HSBC Holdings | 211,304 |
Shell | 96,000 |
Unilever | 115,964 |
British American Tobacco p.l.c. | 48,989 |
Rolls-Royce Holdings | 42,400 |
Rio Tinto Group | 60,000 |
RELX PLC | 36,400 |